DE69501183D1 - Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung - Google Patents

Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung

Info

Publication number
DE69501183D1
DE69501183D1 DE69501183T DE69501183T DE69501183D1 DE 69501183 D1 DE69501183 D1 DE 69501183D1 DE 69501183 T DE69501183 T DE 69501183T DE 69501183 T DE69501183 T DE 69501183T DE 69501183 D1 DE69501183 D1 DE 69501183D1
Authority
DE
Germany
Prior art keywords
gemfibrozil
active ingredient
manufacturing
pharmaceutical preparation
solid oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69501183T
Other languages
English (en)
Other versions
DE69501183T2 (de
Inventor
Pal Dr Fekete
Nee Koehalmi Erzsebet Fellner
Andrea Sandorfalvy
Denes Bezzegh
Gyoergy Dr Ujfalussy
Nee Hernyes Magdolna Gora
Imre Dr Klebovich
Sandor Dr Drabant
Attila Dr Mandi
Nee Kovacs Biborka Maroshelyi
Marta Szanto
Nee Szell Szlavy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of DE69501183D1 publication Critical patent/DE69501183D1/de
Publication of DE69501183T2 publication Critical patent/DE69501183T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69501183T 1994-05-13 1995-05-12 Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung Expired - Fee Related DE69501183T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9401506A HU212428B (en) 1994-05-13 1994-05-13 Process to prepare pharmaceutical compositions containing gemfibrozyl
US08/441,687 US5726201A (en) 1994-05-13 1995-05-15 Gemfibrozil containing pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE69501183D1 true DE69501183D1 (de) 1998-01-22
DE69501183T2 DE69501183T2 (de) 1998-05-07

Family

ID=26318196

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69501183T Expired - Fee Related DE69501183T2 (de) 1994-05-13 1995-05-12 Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung

Country Status (17)

Country Link
US (1) US5726201A (de)
EP (1) EP0684042B1 (de)
JP (1) JP2934941B2 (de)
AT (1) ATE160938T1 (de)
AU (1) AU1768095A (de)
CA (1) CA2149282A1 (de)
CZ (1) CZ287149B6 (de)
DE (1) DE69501183T2 (de)
ES (1) ES2113136T3 (de)
FR (1) FR2719771B1 (de)
GB (1) GB2291349B (de)
GR (1) GR3025749T3 (de)
HR (1) HRP950268B1 (de)
HU (1) HU212428B (de)
IT (1) IT1274483B (de)
PL (1) PL179806B1 (de)
SK (1) SK279927B6 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2329334A (en) * 1997-09-18 1999-03-24 Reckitt & Colmann Prod Ltd Cholesterol-lowering agents
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
JP2004531467A (ja) 2000-11-28 2004-10-14 エフ　エム　シー　コーポレーション 可食性ｐｇａ被覆組成物
US6841865B2 (en) * 2002-11-22 2005-01-11 International Rectifier Corporation Semiconductor device having clips for connecting to external elements
KR100952090B1 (ko) * 2003-10-31 2010-04-13 다케다 야쿠힌 고교 가부시키가이샤 인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌소르비탄 지방산 에스테르를 함유하는 고체 제제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US4126637A (en) * 1977-06-17 1978-11-21 Warner-Lambert Company Process for the production of 2,2-dimethyl-5-(2,5-xylyloxy)valeric acid
US4387107A (en) * 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
EP0179583A1 (de) * 1984-10-04 1986-04-30 Merck & Co. Inc. System zur Verbesserung der Auflösungsgeschwindigkeit in Wasser und der Löslichkeit von schwer löslichen Arzneimitteln
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
US4971804A (en) * 1989-02-02 1990-11-20 Warner-Lambert Company Water dispersible gemfibrozil compositions
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
EP0462067A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil-Formulierung
EP0475894A1 (de) * 1990-08-27 1992-03-18 Warner-Lambert Company Verbesserte Gemfibrozil-Formulierungen
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system

Also Published As

Publication number Publication date
GB2291349B (en) 1998-03-18
HUT70961A (en) 1995-11-28
ATE160938T1 (de) 1997-12-15
CZ287149B6 (en) 2000-09-13
EP0684042B1 (de) 1997-12-10
FR2719771A1 (fr) 1995-11-17
ITMI950961A0 (it) 1995-05-12
CZ122895A3 (en) 1995-12-13
US5726201A (en) 1998-03-10
FR2719771B1 (fr) 1997-01-03
IT1274483B (it) 1997-07-17
ES2113136T3 (es) 1998-04-16
HU9401506D0 (en) 1994-08-29
JPH0899875A (ja) 1996-04-16
ITMI950961A1 (it) 1996-11-12
PL179806B1 (pl) 2000-10-31
EP0684042A3 (de) 1996-05-15
DE69501183T2 (de) 1998-05-07
GR3025749T3 (en) 1998-03-31
SK60595A3 (en) 1996-05-08
EP0684042A2 (de) 1995-11-29
GB2291349A (en) 1996-01-24
JP2934941B2 (ja) 1999-08-16
SK279927B6 (sk) 1999-05-07
PL308580A1 (en) 1995-11-27
HRP950268A2 (en) 1997-08-31
AU1768095A (en) 1995-11-23
CA2149282A1 (en) 1995-11-14
HU212428B (en) 1996-06-28
HRP950268B1 (en) 1999-02-28
GB9509542D0 (en) 1995-07-05

Similar Documents

Publication Publication Date Title
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
UA27899C2 (uk) Порошкова антибактеріальна композиція, що призначена для орального використання, яка містить гідратований цефтибутен
DE69126776T2 (de) Parasitizide zusammensetzung und verfahren zu ihrer herstellung und ihre verwendung
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
ATE148990T1 (de) Ebastin oder ebastin-analoga enthaltende arzneimittel
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
EP0173664A3 (de) Biologisch aktive Benzimidazolderivate und Verfahren zu ihrer Herstellung
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
DE69501183D1 (de) Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung
ATE184788T1 (de) Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer
ATE246515T1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
ATE127465T1 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
NO822276L (no) Preparat for topisk paafoering av legemet.
ATE93383T1 (de) Primycin enthaltende arzneimittelzusammensetzungen.
ES2006521A6 (es) Composicion de control de plagas procedimiento derivados benzopiranicos y benzotiopiranicos y metodo de preparar dicha composicion
SE8205837D0 (sv) Isopropylamino pyrimidine derivative its preparation and therapeutic compositions containing the same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee